Michael Stuart Brown

For other people named Michael Brown, see Michael Brown (disambiguation).

Michael Brown
Born	Michael Stuart Brown (1941-04-13) April 13, 1941 Brooklyn, New York, United States
Nationality	United States
Alma mater	University of Pennsylvania University of Pennsylvania School of Medicine
Known for	Regulation of cholesterol metabolism
Spouse(s)	Alice Lapin (m. 1964)
Children	two
Awards	Heinrich Wieland Prize (1974) Richard Lounsbery Award (1979) William Allan Award (1985) Nobel Prize in Physiology or Medicine (1985) National Medal of Science (1988) ForMemRS (1991)
Scientific career
Fields	Biology
Website	profiles.utsouthwestern.edu/profile/10894/michael-brown.html

Michael Stuart Brown (born April 13, 1941) is an American geneticist and Nobel laureate. He was awarded the Nobel Prize in Physiology or Medicine with Joseph L. Goldstein in 1985 for describing the regulation of cholesterol metabolism.

Education and early life

Brown was born in Brooklyn, New York, the son of Evelyn, a homemaker, and Harvey Brown, a textile salesman. He graduated from Cheltenham High School (Wyncote, Pennsylvania). Brown graduated from the University of Pennsylvania in 1962 and received his M.D. from the University of Pennsylvania School of Medicine in 1966.

Career and research

Moving to the University of Texas Health Science Center in Dallas, now the UT Southwestern Medical Center, Brown and colleague Joseph L. Goldstein researched cholesterol metabolism and discovered that human cells have low-density lipoprotein (LDL) receptors that extract cholesterol from the bloodstream. The lack of sufficient LDL receptors is implicated in familial hypercholesterolemia, which predisposes heavily for cholesterol-related diseases. In addition to explaining the underlying pathology of this disease, their work uncovered a fundamental aspect of cell biology - receptor-mediated endocytosis.

Their findings led to the development of statin drugs, the cholesterol-lowering compounds that today are used by 16 million Americans and are the most widely prescribed medications in the United States. Their discoveries are improving more lives every year, both in the US and around the world. New federal cholesterol guidelines will triple the number of Americans taking statin drugs to lower their cholesterol, reducing the risk of heart disease and stroke for countless people. Following these important advances, their team of dedicated researchers elucidated the role of lipid modification of proteins (protein prenylation) in cancer. In 1984 he was awarded the Louisa Gross Horwitz Prize from Columbia University together with Joseph L. Goldstein (co-recipient of 1985 Nobel Prize in Physiology or Medicine). In 1988, Brown received the National Medal of Science for his contributions to medicine.

In 1993, their trainees Xiaodong Wang and Michael Briggs purified the sterol regulatory element binding proteins (SREBPs). Since 1993, Drs. Brown, Goldstein, and their colleagues have described the unexpectedly complex machinery by which cells maintain the necessary levels of fats and cholesterol in the face of varying environmental circumstances.

Dr. Brown holds the W. A. (Monty) Moncrief Distinguished Chair in Cholesterol and Arteriosclerosis Research; is a Regental Professor of the University of Texas; holds the Paul J. Thomas Chair in Medicine; and is a member of the Board of Scientific Directors at The Scripps Research Institute. Frequently mentioned as a candidate for nationally-prominent positions in scientific administration, Dr. Brown, like his colleague Joseph L. Goldstein, elects to continue hands-on involvement with research, leading a research team that typically includes a dozen doctoral and postdoctoral trainees. He and his colleague are among the most highly cited scientists in the world.

Brown is also on the prestigious Prix Galien USA Committee that "recognizes the technical, scientific and clinical research skills necessary to develop innovative medicines". The inauguration of the Prix Galien in the US, the equivalent of the Nobel Prize in this field, was in September 2007, and the winners were selected by a preeminent scientific and learned committee that included seven Nobel laureates, of which Brown was one.

Awards and honors

Brown has won numerous awards and honors, including:

• 2016 - Keynote Speaker at the Congress of Future Medical Leaders
• 2011 - Stadtman Distinguished Scientist Award, American Society for Biochemistry and Molecular Biology
• 2007 - Builders of Science Award, Research!America
• 2005 - Woodrow Wilson Award for Public Service
• 2005 - Herbert Tabor Award, American Society for Biochemistry and Molecular Biology
• 2003 - Albany Medical Center Prize
• 2002 - Kober Medal, Association of American Physicians
• 1999 - Warren Alpert Foundation Prize, Harvard Medical School
• 1991 - Elected a Foreign Member of the Royal Society (ForMemRS)
• 1988 - National Medal of Science
• 1985 - Nobel Prize for physiology and medicine
• 1985 - Albert Lasker Award for Basic Medical Research
• 1985 - William Allan Award, American Society of Human Genetics
• 1984 - Louisa Gross Horwitz Prize
• 1981 - Gairdner Foundation International Award
• 1980 - elected member of the National Academy of Sciences
• 1979 - Lounsbery Award, U.S. National Academy of Sciences
• 1978 - Passano Award, Johns Hopkins University
• 1976 - Pfizer Award in Enzyme Chemistry, American Chemical Society
• 1974 - Heinrich Wieland Prize

Bibliography

• Brown MS, Goldstein JL (Jul 1974). "Expression of the familial hypercholesterolemia gene in heterozygotes: mechanism for a dominant disorder in man". Science. 185 (4145): 61–3. doi:10.1126/science.185.4145.61. PMID 4366052.
• Brown MS, Goldstein JL (Nov 1975). "Regulation of the activity of the low density lipoprotein receptor in human fibroblasts". Cell. 6 (3): 307–16. doi:10.1016/0092-8674(75)90182-8. PMID 212203.
• Goldstein JL, Basu SK, Brunschede GY, Brown MS (Jan 1976). "Release of low density lipoprotein from its cell surface receptor by sulfated glycosaminoglycans". Cell. 7 (1): 85–95. doi:10.1016/0092-8674(76)90258-0. PMID 181140.
• Brown MS, Goldstein JL (Jan 1976). "Receptor-mediated control of cholesterol metabolism". Science. 191 (4223): 150–4. doi:10.1126/science.174194. PMID 174194.
• Goldstein JL, Sobhani MK, Faust JR, Brown MS (Oct 1976). "Heterozygous familial hypercholesterolemia: failure of normal allele to compensate for mutant allele at a regulated genetic locus". Cell. 9 (2): 195–203. doi:10.1016/0092-8674(76)90110-0. PMID 184960.
• Brown MS, Goldstein JL (Dec 1976). "Analysis of a mutant strain of human fibroblasts with a defect in the internalization of receptor-bound low density lipoprotein". Cell. 9 (4 PT 2): 663–74. doi:10.1016/0092-8674(76)90130-6. PMID 189940.
• Anderson RG, Brown MS, Goldstein JL (Mar 1977). "Role of the coated endocytic vesicle in the uptake of receptor-bound low density lipoprotein in human fibroblasts". Cell. 10 (3): 351–64. doi:10.1016/0092-8674(77)90022-8. PMID 191195.
• Goldstein JL, Brown MS, Stone NJ (Nov 1977). "Genetics of the LDL receptor: evidence that the mutations affecting binding and internalization are allelic". Cell. 12 (3): 629–41. doi:10.1016/0092-8674(77)90263-X. PMID 200368.
• Anderson RG, Goldstein JL, Brown MS (1977). "A mutation that impairs the ability of lipoprotein receptors to localise in coated pits on the cell surface of human fibroblasts". Nature. 270 (5639): 695–9. doi:10.1038/270695a0. PMID 201867.
• Anderson RG, Vasile E, Mello RJ, Brown MS, Goldstein JL (Nov 1978). "Immunocytochemical visualization of coated pits and vesicles in human fibroblasts: relation to low density lipoprotein receptor distribution". Cell. 15 (3): 919–33. doi:10.1016/0092-8674(78)90276-3. PMID 215316.
• Goldstein JL, Anderson RG, Brown MS (Jun 1979). "Coated pits, coated vesicles, and receptor-mediated endocytosis". Nature. 279 (5715): 679–85. doi:10.1038/279679a0. PMID 221835.
• Mello RJ, Brown MS, Goldstein JL, Anderson RG (Jul 1980). "LDL receptors in coated vesicles isolated from bovine adrenal cortex: binding sites unmasked by detergent treatment". Cell. 20 (3): 829–37. doi:10.1016/0092-8674(80)90329-3. PMID 6251975.
• Brown MS, Kovanen PT, Goldstein JL (May 1981). "Regulation of plasma cholesterol by lipoprotein receptors". Science. 212 (4495): 628–35. doi:10.1126/science.6261329. PMID 6261329.
• Basu SK, Goldstein JL, Anderson RG, Brown MS (May 1981). "Monensin interrupts the recycling of low density lipoprotein receptors in human fibroblasts". Cell. 24 (2): 493–502. doi:10.1016/0092-8674(81)90340-8. PMID 6263497.
• Tolleshaug H, Goldstein JL, Schneider WJ, Brown MS (Oct 1982). "Posttranslational processing of the LDL receptor and its genetic disruption in familial hypercholesterolemia". Cell. 30 (3): 715–24. doi:10.1016/0092-8674(82)90276-8. PMID 6291781.
• Basu SK, Goldstein JL, Brown MS (Feb 1983). "Independent pathways for secretion of cholesterol and apolipoprotein E by macrophages". Science. 219 (4586): 871–3. doi:10.1126/science.6823554. PMID 6823554.
• Brown MS, Anderson RG, Goldstein JL (Mar 1983). "Recycling receptors: the round-trip itinerary of migrant membrane proteins". Cell. 32 (3): 663–7. doi:10.1016/0092-8674(83)90052-1. PMID 6299572.
• Tolleshaug H, Hobgood KK, Brown MS, Goldstein JL (Mar 1983). "The LDL receptor locus in familial hypercholesterolemia: multiple mutations disrupt transport and processing of a membrane receptor". Cell. 32 (3): 941–51. doi:10.1016/0092-8674(83)90079-X. PMID 6299582.
• Larkin JM, Brown MS, Goldstein JL, Anderson RG (May 1983). "Depletion of intracellular potassium arrests coated pit formation and receptor-mediated endocytosis in fibroblasts". Cell. 33 (1): 273–85. doi:10.1016/0092-8674(83)90356-2. PMID 6147196.
• Orci L, Brown MS, Goldstein JL, Garcia-Segura LM, Anderson RG (Apr 1984). "Increase in membrane cholesterol: a possible trigger for degradation of HMG CoA reductase and crystalloid endoplasmic reticulum in UT-1 cells". Cell. 36 (4): 835–45. doi:10.1016/0092-8674(84)90033-3. PMID 6705048.
• Chin DJ, Gil G, Russell DW, et al. (1984). "Nucleotide sequence of 3-hydroxy-3-methyl-glutaryl coenzyme A reductase, a glycoprotein of endoplasmic reticulum". Nature. 308 (5960): 613–7. doi:10.1038/308613a0. PMID 6546784.
• Russell DW, Schneider WJ, Yamamoto T, Luskey KL, Brown MS, Goldstein JL (Jun 1984). "Domain map of the LDL receptor: sequence homology with the epidermal growth factor precursor". Cell. 37 (2): 577–85. doi:10.1016/0092-8674(84)90388-X. PMID 6327078.
• Reynolds GA, Basu SK, Osborne TF, et al. (Aug 1984). "HMG CoA reductase: a negatively regulated gene with unusual promoter and 5' untranslated regions". Cell. 38 (1): 275–85. doi:10.1016/0092-8674(84)90549-X. PMID 6088070.
• Yamamoto T, Davis CG, Brown MS, et al. (Nov 1984). "The human LDL receptor: a cysteine-rich protein with multiple Alu sequences in its mRNA". Cell. 39 (1): 27–38. doi:10.1016/0092-8674(84)90188-0. PMID 6091915.
• Lehrman MA, Schneider WJ, Südhof TC, Brown MS, Goldstein JL, Russell DW (Jan 1985). "Mutation in LDL receptor: Alu-Alu recombination deletes exons encoding transmembrane and cytoplasmic domains". Science. 227 (4683): 140–6. doi:10.1126/science.3155573. PMID 3155573.
• Südhof TC, Goldstein JL, Brown MS, Russell DW (May 1985). "The LDL receptor gene: a mosaic of exons shared with different proteins". Science. 228 (4701): 815–22. doi:10.1126/science.2988123. PMC 4450672. PMID 2988123.
• Südhof TC, Russell DW, Goldstein JL, Brown MS, Sanchez-Pescador R, Bell GI (May 1985). "Cassette of eight exons shared by genes for LDL receptor and EGF precursor". Science. 228 (4701): 893–5. doi:10.1126/science.3873704. PMID 3873704.
• Gil G, Faust JR, Chin DJ, Goldstein JL, Brown MS (May 1985). "Membrane-bound domain of HMG CoA reductase is required for sterol-enhanced degradation of the enzyme". Cell. 41 (1): 249–58. doi:10.1016/0092-8674(85)90078-9. PMID 3995584.
• Lehrman MA, Goldstein JL, Brown MS, Russell DW, Schneider WJ (Jul 1985). "Internalization-defective LDL receptors produced by genes with nonsense and frameshift mutations that truncate the cytoplasmic domain". Cell. 41 (3): 735–43. doi:10.1016/S0092-8674(85)80054-4. PMID 3924410.
• Osborne TF, Goldstein JL, Brown MS (Aug 1985). "5' end of HMG CoA reductase gene contains sequences responsible for cholesterol-mediated inhibition of transcription". Cell. 42 (1): 203–12. doi:10.1016/S0092-8674(85)80116-1. PMID 3860301.
• Brown MS, Goldstein JL (1985). "Scavenger cell receptor shared". Nature. 316 (6030): 680–1. doi:10.1038/316680a0. PMID 4033768.
• Brown MS, Goldstein JL (Apr 1986). "A receptor-mediated pathway for cholesterol homeostasis". Science. 232 (4746): 34–47. doi:10.1126/science.3513311. PMID 3513311.
• Davis CG, Lehrman MA, Russell DW, Anderson RG, Brown MS, Goldstein JL (Apr 1986). "The J.D. mutation in familial hypercholesterolemia: amino acid substitution in cytoplasmic domain impedes internalization of LDL receptors". Cell. 45 (1): 15–24. doi:10.1016/0092-8674(86)90533-7. PMID 3955657.
• Yamamoto T, Bishop RW, Brown MS, Goldstein JL, Russell DW (Jun 1986). "Deletion in cysteine-rich region of LDL receptor impedes transport to cell surface in WHHL rabbit". Science. 232 (4755): 1230–7. doi:10.1126/science.3010466. PMC 4451858. PMID 3010466.
• Lehrman MA, Goldstein JL, Russell DW, Brown MS (Mar 1987). "Duplication of seven exons in LDL receptor gene caused by Alu-Alu recombination in a subject with familial hypercholesterolemia". Cell. 48 (5): 827–35. doi:10.1016/0092-8674(87)90079-1. PMID 3815525.
• Südhof TC, Russell DW, Brown MS, Goldstein JL (Mar 1987). "42 bp element from LDL receptor gene confers end-product repression by sterols when inserted into viral TK promoter". Cell. 48 (6): 1061–9. doi:10.1016/0092-8674(87)90713-6. PMID 3030558.
• Davis CG, Goldstein JL, Südhof TC, Anderson RG, Russell DW, Brown MS (1987). "Acid-dependent ligand dissociation and recycling of LDL receptor mediated by growth factor homology region". Nature. 326 (6115): 760–5. doi:10.1038/326760a0. PMID 3494949.
• Hofmann SL, Russell DW, Brown MS, Goldstein JL, Hammer RE (Mar 1988). "Overexpression of low density lipoprotein (LDL) receptor eliminates LDL from plasma in transgenic mice". Science. 239 (4845): 1277–81. doi:10.1126/science.3344433. PMID 3344433.
• Reiss Y, Goldstein JL, Seabra MC, Casey PJ, Brown MS (Jul 1990). "Inhibition of purified p21ras farnesyl:protein transferase by Cys-AAX tetrapeptides". Cell. 62 (1): 81–8. doi:10.1016/0092-8674(90)90242-7. PMID 2194674.
• Yokode M, Hammer RE, Ishibashi S, Brown MS, Goldstein JL (Nov 1990). "Diet-induced hypercholesterolemia in mice: prevention by overexpression of LDL receptors". Science. 250 (4985): 1273–5. doi:10.1126/science.2244210. PMID 2244210.
• Seabra MC, Reiss Y, Casey PJ, Brown MS, Goldstein JL (May 1991). "Protein farnesyltransferase and geranylgeranyltransferase share a common alpha subunit". Cell. 65 (3): 429–34. doi:10.1016/0092-8674(91)90460-G. PMID 2018975.
• Chen WJ, Andres DA, Goldstein JL, Russell DW, Brown MS (Jul 1991). "cDNA cloning and expression of the peptide-binding beta subunit of rat p21ras farnesyltransferase, the counterpart of yeast DPR1/RAM1". Cell. 66 (2): 327–34. doi:10.1016/0092-8674(91)90622-6. PMID 1855253.
• Seabra MC, Brown MS, Slaughter CA, Südhof TC, Goldstein JL (Sep 1992). "Purification of component A of Rab geranylgeranyl transferase: possible identity with the choroideremia gene product". Cell. 70 (6): 1049–57. doi:10.1016/0092-8674(92)90253-9. PMID 1525821.
• Brown MS, Goldstein JL (Oct 1992). "Koch's postulates for cholesterol". Cell. 71 (2): 187–8. doi:10.1016/0092-8674(92)90346-E. PMID 1423585.
• Andres DA, Seabra MC, Brown MS, et al. (Jun 1993). "cDNA cloning of component A of Rab geranylgeranyl transferase and demonstration of its role as a Rab escort protein". Cell. 73 (6): 1091–9. doi:10.1016/0092-8674(93)90639-8. PMID 8513495.
• Yokoyama C, Wang X, Briggs MR, et al. (Oct 1993). "SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene". Cell. 75 (1): 187–97. doi:10.1016/S0092-8674(05)80095-9. PMID 8402897.
• Garcia CK, Goldstein JL, Pathak RK, Anderson RG, Brown MS (Mar 1994). "Molecular characterization of a membrane transporter for lactate, pyruvate, and other monocarboxylates: implications for the Cori cycle". Cell. 76 (5): 865–73. doi:10.1016/0092-8674(94)90361-1. PMID 8124722.
• Wang X, Sato R, Brown MS, Hua X, Goldstein JL (Apr 1994). "SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis". Cell. 77 (1): 53–62. doi:10.1016/0092-8674(94)90234-8. PMID 8156598.
• Sakai J, Duncan EA, Rawson RB, Hua X, Brown MS, Goldstein JL (Jun 1996). "Sterol-regulated release of SREBP-2 from cell membranes requires two sequential cleavages, one within a transmembrane segment". Cell. 85 (7): 1037–46. doi:10.1016/S0092-8674(00)81304-5. PMID 8674110.
• Hua X, Nohturfft A, Goldstein JL, Brown MS (Nov 1996). "Sterol resistance in CHO cells traced to point mutation in SREBP cleavage-activating protein". Cell. 87 (3): 415–26. doi:10.1016/S0092-8674(00)81362-8. PMID 8898195.
• Brown MS, Goldstein JL (May 1997). "The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor". Cell. 89 (3): 331–40. doi:10.1016/S0092-8674(00)80213-5. PMID 9150132.
• DeBose-Boyd RA, Brown MS, Li WP, Nohturfft A, Goldstein JL, Espenshade PJ (Dec 1999). "Transport-dependent proteolysis of SREBP: relocation of site-1 protease from Golgi to ER obviates the need for SREBP transport to Golgi". Cell. 99 (7): 703–12. doi:10.1016/S0092-8674(00)81668-2. PMID 10619424.
• Brown MS, Ye J, Rawson RB, Goldstein JL (Feb 2000). "Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans". Cell. 100 (4): 391–8. doi:10.1016/S0092-8674(00)80675-3. PMID 10693756.
• Nohturfft A, Yabe D, Goldstein JL, Brown MS, Espenshade PJ (Aug 2000). "Regulated step in cholesterol feedback localized to budding of SCAP from ER membranes". Cell. 102 (3): 315–23. doi:10.1016/S0092-8674(00)00037-4. PMID 10975522.
• Yang T, Espenshade PJ, Wright ME, et al. (Aug 2002). "Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER". Cell. 110 (4): 489–500. doi:10.1016/S0092-8674(02)00872-3. PMID 12202038.